The protective potential of alpha lipoic acid on amiodarone-induced pulmonary fibrosis and hepatic injury in rats

Amiodarone (AMD) is a widely used antiarrhythmic drug prescribed to treat cardiac tachyarrhythmias; however, AMD has been reported to provoke pulmonary fibrosis (PF) and hepatotoxicity. This study aimed to investigate the influence of alpha lipoic acid (ALA) on AMD-induced PF and hepatotoxicity in m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular and cellular biochemistry 2021-09, Vol.476 (9), p.3433-3448
Hauptverfasser: Ibrahim Fouad, Ghadha, R. Mousa, Mohamed
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3448
container_issue 9
container_start_page 3433
container_title Molecular and cellular biochemistry
container_volume 476
creator Ibrahim Fouad, Ghadha
R. Mousa, Mohamed
description Amiodarone (AMD) is a widely used antiarrhythmic drug prescribed to treat cardiac tachyarrhythmias; however, AMD has been reported to provoke pulmonary fibrosis (PF) and hepatotoxicity. This study aimed to investigate the influence of alpha lipoic acid (ALA) on AMD-induced PF and hepatotoxicity in male Wistar rats. AMD administration resulted in elevated lung contents of hydroxyproline (Hyp), malondialdehyde (MDA), and increased serum levels of transforming growth factor beta-1 (TGF-β1), interferon-γ (IFN-γ), alanine amino transaminase (ALT), aspartate amino transaminase (AST), total cholesterol (TC), and glucose. On the other side, lung content of glutathione reduced (GSH) and serum levels of total anti-oxidant capacity (TAC) were significantly decreased. Histopathologically, AMD caused PF, produced a mild hepatic injury, and increased expression of alpha smooth muscle actin (α-SMA). Treatment with ALA produced a significant reversal of the oxidative stress, fibrosis, and inflammation parameters with reductions in α-SMA expressions, leading to amelioration of histopathological lesions. ALA might provide supportive therapy in AMD-receiving cardiovascular patients.
doi_str_mv 10.1007/s11010-021-04173-7
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2558271817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A670977334</galeid><sourcerecordid>A670977334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-429701ba042be7557bd698fc8ce5184e6c7aa4e9b6e5ea894e185ddfc6a90d543</originalsourceid><addsrcrecordid>eNp9UcFu1TAQtBCIvhZ-gAOyxDnFG9txfKwqCpUqcSlny7E3fX5K7NROkPh7_HiFCgkhH7zyzox3Zwh5B-wSGFMfCwAD1rAWGiZA8Ua9IDuQtRAa9EuyY5yxpgelzsh5KQdW0QzgNTnjXCsOHHbk8X6PdMlpRbeG77WsVVyDnWgaqZ2WvaVTWFJw1LrgaYrUziF5m1PEJkS_OfR02aY5RZt_0DEMOZVQqI2e7nGxa2WGeNhqL0Sa7VrekFejnQq-fbovyLebT_fXX5q7r59vr6_uGidEuzai1YrBYJloB1RSqsF3uh9d71BCL7BzylqBeuhQou21QOil96PrrGZeCn5BPpx063aPG5bVHNKWY_3StFL2rYLqzDPqwU5oQhzTmq2bQ3HmqlNMK8X5UevyH6h6PM7BVSvGUN__IrQngqt2lIyjWXKYq0MGmDmGZ07hmRqe-RWeOc7y_mnibZjR_6H8TqsC-AlQais-YH5e6T-yPwEtpaSg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2558271817</pqid></control><display><type>article</type><title>The protective potential of alpha lipoic acid on amiodarone-induced pulmonary fibrosis and hepatic injury in rats</title><source>SpringerLink Journals - AutoHoldings</source><creator>Ibrahim Fouad, Ghadha ; R. Mousa, Mohamed</creator><creatorcontrib>Ibrahim Fouad, Ghadha ; R. Mousa, Mohamed</creatorcontrib><description>Amiodarone (AMD) is a widely used antiarrhythmic drug prescribed to treat cardiac tachyarrhythmias; however, AMD has been reported to provoke pulmonary fibrosis (PF) and hepatotoxicity. This study aimed to investigate the influence of alpha lipoic acid (ALA) on AMD-induced PF and hepatotoxicity in male Wistar rats. AMD administration resulted in elevated lung contents of hydroxyproline (Hyp), malondialdehyde (MDA), and increased serum levels of transforming growth factor beta-1 (TGF-β1), interferon-γ (IFN-γ), alanine amino transaminase (ALT), aspartate amino transaminase (AST), total cholesterol (TC), and glucose. On the other side, lung content of glutathione reduced (GSH) and serum levels of total anti-oxidant capacity (TAC) were significantly decreased. Histopathologically, AMD caused PF, produced a mild hepatic injury, and increased expression of alpha smooth muscle actin (α-SMA). Treatment with ALA produced a significant reversal of the oxidative stress, fibrosis, and inflammation parameters with reductions in α-SMA expressions, leading to amelioration of histopathological lesions. ALA might provide supportive therapy in AMD-receiving cardiovascular patients.</description><identifier>ISSN: 0300-8177</identifier><identifier>EISSN: 1573-4919</identifier><identifier>DOI: 10.1007/s11010-021-04173-7</identifier><identifier>PMID: 33973131</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Actin ; Alanine ; Amiodarone ; Antioxidants ; Aspartate ; Biochemistry ; Biological response modifiers ; Biomedical and Life Sciences ; Cardiology ; Cholesterol ; Fibrosis ; Glutathione ; Growth factors ; Hepatotoxicity ; Hydroxyproline ; Inflammation ; Interferon ; Life Sciences ; Lipoic acid ; Liver ; Lung diseases ; Lungs ; Malondialdehyde ; Medical Biochemistry ; Muscle proteins ; Muscles ; Oncology ; Oxidants ; Oxidative stress ; Oxidizing agents ; Pulmonary fibrosis ; Rodents ; Serum levels ; Smooth muscle ; Transaminase ; Transaminases ; Transforming growth factor-b1 ; Transforming growth factors ; γ-Interferon</subject><ispartof>Molecular and cellular biochemistry, 2021-09, Vol.476 (9), p.3433-3448</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>COPYRIGHT 2021 Springer</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-429701ba042be7557bd698fc8ce5184e6c7aa4e9b6e5ea894e185ddfc6a90d543</citedby><cites>FETCH-LOGICAL-c442t-429701ba042be7557bd698fc8ce5184e6c7aa4e9b6e5ea894e185ddfc6a90d543</cites><orcidid>0000-0003-3665-3153</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11010-021-04173-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11010-021-04173-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27926,27927,41490,42559,51321</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33973131$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ibrahim Fouad, Ghadha</creatorcontrib><creatorcontrib>R. Mousa, Mohamed</creatorcontrib><title>The protective potential of alpha lipoic acid on amiodarone-induced pulmonary fibrosis and hepatic injury in rats</title><title>Molecular and cellular biochemistry</title><addtitle>Mol Cell Biochem</addtitle><addtitle>Mol Cell Biochem</addtitle><description>Amiodarone (AMD) is a widely used antiarrhythmic drug prescribed to treat cardiac tachyarrhythmias; however, AMD has been reported to provoke pulmonary fibrosis (PF) and hepatotoxicity. This study aimed to investigate the influence of alpha lipoic acid (ALA) on AMD-induced PF and hepatotoxicity in male Wistar rats. AMD administration resulted in elevated lung contents of hydroxyproline (Hyp), malondialdehyde (MDA), and increased serum levels of transforming growth factor beta-1 (TGF-β1), interferon-γ (IFN-γ), alanine amino transaminase (ALT), aspartate amino transaminase (AST), total cholesterol (TC), and glucose. On the other side, lung content of glutathione reduced (GSH) and serum levels of total anti-oxidant capacity (TAC) were significantly decreased. Histopathologically, AMD caused PF, produced a mild hepatic injury, and increased expression of alpha smooth muscle actin (α-SMA). Treatment with ALA produced a significant reversal of the oxidative stress, fibrosis, and inflammation parameters with reductions in α-SMA expressions, leading to amelioration of histopathological lesions. ALA might provide supportive therapy in AMD-receiving cardiovascular patients.</description><subject>Actin</subject><subject>Alanine</subject><subject>Amiodarone</subject><subject>Antioxidants</subject><subject>Aspartate</subject><subject>Biochemistry</subject><subject>Biological response modifiers</subject><subject>Biomedical and Life Sciences</subject><subject>Cardiology</subject><subject>Cholesterol</subject><subject>Fibrosis</subject><subject>Glutathione</subject><subject>Growth factors</subject><subject>Hepatotoxicity</subject><subject>Hydroxyproline</subject><subject>Inflammation</subject><subject>Interferon</subject><subject>Life Sciences</subject><subject>Lipoic acid</subject><subject>Liver</subject><subject>Lung diseases</subject><subject>Lungs</subject><subject>Malondialdehyde</subject><subject>Medical Biochemistry</subject><subject>Muscle proteins</subject><subject>Muscles</subject><subject>Oncology</subject><subject>Oxidants</subject><subject>Oxidative stress</subject><subject>Oxidizing agents</subject><subject>Pulmonary fibrosis</subject><subject>Rodents</subject><subject>Serum levels</subject><subject>Smooth muscle</subject><subject>Transaminase</subject><subject>Transaminases</subject><subject>Transforming growth factor-b1</subject><subject>Transforming growth factors</subject><subject>γ-Interferon</subject><issn>0300-8177</issn><issn>1573-4919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9UcFu1TAQtBCIvhZ-gAOyxDnFG9txfKwqCpUqcSlny7E3fX5K7NROkPh7_HiFCgkhH7zyzox3Zwh5B-wSGFMfCwAD1rAWGiZA8Ua9IDuQtRAa9EuyY5yxpgelzsh5KQdW0QzgNTnjXCsOHHbk8X6PdMlpRbeG77WsVVyDnWgaqZ2WvaVTWFJw1LrgaYrUziF5m1PEJkS_OfR02aY5RZt_0DEMOZVQqI2e7nGxa2WGeNhqL0Sa7VrekFejnQq-fbovyLebT_fXX5q7r59vr6_uGidEuzai1YrBYJloB1RSqsF3uh9d71BCL7BzylqBeuhQou21QOil96PrrGZeCn5BPpx063aPG5bVHNKWY_3StFL2rYLqzDPqwU5oQhzTmq2bQ3HmqlNMK8X5UevyH6h6PM7BVSvGUN__IrQngqt2lIyjWXKYq0MGmDmGZ07hmRqe-RWeOc7y_mnibZjR_6H8TqsC-AlQais-YH5e6T-yPwEtpaSg</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Ibrahim Fouad, Ghadha</creator><creator>R. Mousa, Mohamed</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0003-3665-3153</orcidid></search><sort><creationdate>20210901</creationdate><title>The protective potential of alpha lipoic acid on amiodarone-induced pulmonary fibrosis and hepatic injury in rats</title><author>Ibrahim Fouad, Ghadha ; R. Mousa, Mohamed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-429701ba042be7557bd698fc8ce5184e6c7aa4e9b6e5ea894e185ddfc6a90d543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Actin</topic><topic>Alanine</topic><topic>Amiodarone</topic><topic>Antioxidants</topic><topic>Aspartate</topic><topic>Biochemistry</topic><topic>Biological response modifiers</topic><topic>Biomedical and Life Sciences</topic><topic>Cardiology</topic><topic>Cholesterol</topic><topic>Fibrosis</topic><topic>Glutathione</topic><topic>Growth factors</topic><topic>Hepatotoxicity</topic><topic>Hydroxyproline</topic><topic>Inflammation</topic><topic>Interferon</topic><topic>Life Sciences</topic><topic>Lipoic acid</topic><topic>Liver</topic><topic>Lung diseases</topic><topic>Lungs</topic><topic>Malondialdehyde</topic><topic>Medical Biochemistry</topic><topic>Muscle proteins</topic><topic>Muscles</topic><topic>Oncology</topic><topic>Oxidants</topic><topic>Oxidative stress</topic><topic>Oxidizing agents</topic><topic>Pulmonary fibrosis</topic><topic>Rodents</topic><topic>Serum levels</topic><topic>Smooth muscle</topic><topic>Transaminase</topic><topic>Transaminases</topic><topic>Transforming growth factor-b1</topic><topic>Transforming growth factors</topic><topic>γ-Interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ibrahim Fouad, Ghadha</creatorcontrib><creatorcontrib>R. Mousa, Mohamed</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Molecular and cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ibrahim Fouad, Ghadha</au><au>R. Mousa, Mohamed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The protective potential of alpha lipoic acid on amiodarone-induced pulmonary fibrosis and hepatic injury in rats</atitle><jtitle>Molecular and cellular biochemistry</jtitle><stitle>Mol Cell Biochem</stitle><addtitle>Mol Cell Biochem</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>476</volume><issue>9</issue><spage>3433</spage><epage>3448</epage><pages>3433-3448</pages><issn>0300-8177</issn><eissn>1573-4919</eissn><abstract>Amiodarone (AMD) is a widely used antiarrhythmic drug prescribed to treat cardiac tachyarrhythmias; however, AMD has been reported to provoke pulmonary fibrosis (PF) and hepatotoxicity. This study aimed to investigate the influence of alpha lipoic acid (ALA) on AMD-induced PF and hepatotoxicity in male Wistar rats. AMD administration resulted in elevated lung contents of hydroxyproline (Hyp), malondialdehyde (MDA), and increased serum levels of transforming growth factor beta-1 (TGF-β1), interferon-γ (IFN-γ), alanine amino transaminase (ALT), aspartate amino transaminase (AST), total cholesterol (TC), and glucose. On the other side, lung content of glutathione reduced (GSH) and serum levels of total anti-oxidant capacity (TAC) were significantly decreased. Histopathologically, AMD caused PF, produced a mild hepatic injury, and increased expression of alpha smooth muscle actin (α-SMA). Treatment with ALA produced a significant reversal of the oxidative stress, fibrosis, and inflammation parameters with reductions in α-SMA expressions, leading to amelioration of histopathological lesions. ALA might provide supportive therapy in AMD-receiving cardiovascular patients.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33973131</pmid><doi>10.1007/s11010-021-04173-7</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0003-3665-3153</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0300-8177
ispartof Molecular and cellular biochemistry, 2021-09, Vol.476 (9), p.3433-3448
issn 0300-8177
1573-4919
language eng
recordid cdi_proquest_journals_2558271817
source SpringerLink Journals - AutoHoldings
subjects Actin
Alanine
Amiodarone
Antioxidants
Aspartate
Biochemistry
Biological response modifiers
Biomedical and Life Sciences
Cardiology
Cholesterol
Fibrosis
Glutathione
Growth factors
Hepatotoxicity
Hydroxyproline
Inflammation
Interferon
Life Sciences
Lipoic acid
Liver
Lung diseases
Lungs
Malondialdehyde
Medical Biochemistry
Muscle proteins
Muscles
Oncology
Oxidants
Oxidative stress
Oxidizing agents
Pulmonary fibrosis
Rodents
Serum levels
Smooth muscle
Transaminase
Transaminases
Transforming growth factor-b1
Transforming growth factors
γ-Interferon
title The protective potential of alpha lipoic acid on amiodarone-induced pulmonary fibrosis and hepatic injury in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T13%3A20%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20protective%20potential%20of%20alpha%20lipoic%20acid%20on%20amiodarone-induced%20pulmonary%20fibrosis%20and%20hepatic%20injury%20in%20rats&rft.jtitle=Molecular%20and%20cellular%20biochemistry&rft.au=Ibrahim%20Fouad,%20Ghadha&rft.date=2021-09-01&rft.volume=476&rft.issue=9&rft.spage=3433&rft.epage=3448&rft.pages=3433-3448&rft.issn=0300-8177&rft.eissn=1573-4919&rft_id=info:doi/10.1007/s11010-021-04173-7&rft_dat=%3Cgale_proqu%3EA670977334%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2558271817&rft_id=info:pmid/33973131&rft_galeid=A670977334&rfr_iscdi=true